Real-world data of fulvestrant as first-line treatment of postmenopausal women with estrogen receptor-positive metastatic breast cancer

por Blancas, I., Olier, C., Conde, V., Bayo, J. L., Herrero, C., Zarcos-Pedrinaci, I., Carabantes, F., Baena-Cañada, J. M., Cruz, J., Ruiz-Borrego, M.
Publicado 2021

Phase II study of capecitabine in combination with paclitaxel in patients with anthracycline-pretreated advanced/metastatic breast cancer

por Batista, N, Perez-Manga, G, Constenla, M, Ruiz, A, Carabantes, F, Castellanos, J, Gonzalez Barón, M, Villman, K, Söderberg, M, Ahlgren, J, Casinello, J, Regueiro, P, Murias, A
Publicado 2004

Letrozole efficacy is related to human aromatase CYP19 single nucleotide polymorphisms (SNPs) in metastatic breast cancer

por Colomer, R, Monzo, M, Tusquets, I, Rifa, J, Baena, JM, Barnadas, A, Calvo, L, Carabantes, F, Crespo, C, Muñoz, M, Llombart, A, Plazaola, A, Alba, E, Fuster, D, Gilabert, M, Lloveras, B
Publicado 2005